Related Experiment Video
Updated: Mar 26, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
Viperatoxin-II: A novel viper venom protein as an effective bactericidal agent
Ramar Perumal Samy1, Bradley G Stiles2, Arunachalam Chinnathambi3
1Venom and Toxin Research Programme, Department of Anatomy, Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore, Singapore 117597; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, NUHS, National University of Singapore, Singapore 117597; Department of Physiology, NUS Immunology Programme, Centre for Life Sciences, Yong Loo Lin School of Medicine, NUHS, National University of Singapore, Singapore 117456.
Abstract:
Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) have become a rising threat to public health. There is an urgent need for development of promising new therapeutic agents against drug resistant bacteria like S. aureus. This report discusses purification and characterization of proteins from Indian Russell's viper snake venom. Novel 15-kDa proteins called "Viperatoxin" (VipTx-I and VipTx-II) were extracted from the whole venom and evaluated using in vitro antimicrobial experiments. The N-terminal amino acid sequence of "Viperatoxin" showed high sequence homology to daboiatoxin isolated from the same venom and also matched phospholipase A2 (PLA2) enzymes isolated from other snake venoms. In an in vitro plate assay, VipTx-II but not VipTx-I showed strong antimicrobial effects against S. aureus and Burkholderia pseudomallei (KHW & TES), Proteus vulgaris and P. mirabilis. The VipTx-II was further tested by a broth-dilution assay at 100-3.1 μg/ml concentrations. The most potent bactericidal effect was found at the lowest dilutions (MICs of 6.25 μg/ml) against B. pseudomallei, S. aureus and P. vulgaris (MICs of 12.25 μg/ml). Electron microscopic investigation revealed that the protein-induced bactericidal potency was closely associated with pore formation and membrane damage, even at the lowest concentrations (<20 μg/ml). The toxin caused a low level of cytotoxic effects as observed in human (THP-1) cells at higher concentrations. Molecular weight determinations of VipTx-II by sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed one major, along with a few minor bands. The results indicate that VipTx-II plays a significant role in bactericidal and membrane damaging effects in vitro. Non-cytotoxic properties on human cells highlight it as a promising candidate for further evaluation of antimicrobial potential in vivo.
Insights
Novel proteins from Indian Russell's viper venom, called Viperatoxin (VipTx-I and VipTx-II), show antimicrobial activity. VipTx-II effectively kills bacteria like methicillin-resistant Staphylococcus aureus (MRSA) by damaging cell membranes.
Area of Science:
- Biochemistry
- Microbiology
- Toxicology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) infections pose a significant public health threat.
- There is an urgent need for novel therapeutic agents against drug-resistant bacteria.
- Indian Russell's viper venom is a potential source of bioactive compounds.
Purpose of the Study:
- To purify and characterize novel proteins from Indian Russell's viper venom.
- To evaluate the antimicrobial potential of these proteins against pathogenic bacteria.
- To investigate the mechanism of action of the identified antimicrobial protein.
Main Methods:
- Purification of 15-kDa proteins (Viperatoxin, VipTx-I and VipTx-II) from whole venom.
- In vitro antimicrobial assays (plate and broth-dilution) against various bacterial strains.
- N-terminal amino acid sequencing, molecular weight determination (SDS-PAGE), and electron microscopy.
Main Results:
- VipTx-II exhibited potent in vitro antimicrobial activity against S. aureus, B. pseudomallei, P. vulgaris, and P. mirabilis.
- Minimum inhibitory concentrations (MICs) for VipTx-II were as low as 6.25 μg/ml against B. pseudomallei.
- Electron microscopy revealed that VipTx-II induced bacterial membrane damage and pore formation.
- VipTx-II showed low cytotoxicity on human THP-1 cells at higher concentrations.
Conclusions:
- VipTx-II is a promising antimicrobial agent derived from snake venom.
- The protein's bactericidal effect is mediated by membrane damage.
- VipTx-II's low cytotoxicity suggests potential for in vivo antimicrobial applications.
Related Concept Videos
Bacterial Toxins
Diphtheria
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Regulation of Bacterial Virulence
Chemical Agents for Microbial Control

